R 0012/10 of 14.12.2011
- European Case Law Identifier
- ECLI:EP:BA:2011:R001210.20111214
- Date of decision
- 14 December 2011
- Case number
- R 0012/10
- Petition for review of
- T 0232/08 2010-05-07
- Application number
- 98911246.1
- IPC class
- A61K 38/16
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen and members (B)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid
- Applicant name
- LG Life Sciences, Ltd.
- Opponent name
- Quadrant Drug Delivery Limited
- Board
- -
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 112a(2)(c)European Patent Convention Art 112a(2)(d)European Patent Convention Art 112a(4)European Patent Convention Art 113European Patent Convention R 104European Patent Convention R 111(2)
- Keywords
- Inconsistency in the decision (no)
Petition for review as far as not rejected as clearly inadmissible, rejected as clearly not allowable - Catchword
- -
- Cited cases
- -
- Citing cases
- -
ORDER
For these reasons it is decided that:
To the extent that the petition for review is not rejected as clearly inadmissible, it is rejected as clearly unallowable.